Clinical Trial Update: Efficacy and Tolerance of Cannabidiol in Patients with Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study [Phase 3]

View source ↗

Summary

A Phase 3 multicenter, double-blind, randomized, placebo-controlled trial evaluating cannabidiol for severe pruritus; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: University Hospital, Brest | Conditions: Pruritus | Phase 3 | Status: NOT_YET_RECRUITING